Penn State Senators pass SB 1225 for a no-cost breast MRI, and SB 1330 for genetic testing and counseling at no cost
Harrisburg – The PA Breast Cancer Coalition (PBCC), along with PA Senate Majority Leader Kim Ward (R-Westmoreland) and PA Senator Bob Minch (R-Montgomery) announced this week (October 19) the approval of the PA Council of Senators on two bills for women at high risk of breast cancer: Senate Bill 1225 for no-cost breast MRI and ultrasound and Senate Bill 1330 for no-cost genetic testing and counseling.
“Both Senate Bill 1225 and Senate Bill 1330 will provide Pennsylvania women with the best possible tools for detecting early, most treatable breast cancer — without having to worry about cost,” said Pat Halpin Murphy, president of PBCC. “We applaud the combined efforts of Senator Bob Minch and Senator Kim Ward that will undoubtedly save lives.”
Senate Bill 1225, sponsored by Senator Minch, eliminates the costs of breast MRI and ultrasound for women with high-risk conditions such as dense breast tissue, a family history of breast cancer, a personal history of breast cancer, or a genetic predisposition or prior radiotherapy. According to a study published in the Journal of the American Medical Association (JAMA), a breast MRI is more than twice as likely to detect breast cancer than a 3-D mammogram in high-risk women.
“These votes bring us one step closer to ensuring that high-risk women in Pennsylvania have affordable access to early detection of breast cancer,” said Senator Bob Minch, sponsor of SB1225. “I am proud to partner with the PA Breast Cancer Alliance on this 4The tenth A piece of legislation that I think will have an impact on countless lives and reduce the number of late stage diagnoses going forward.”
Senate Bill 1330, sponsored by Senate Majority Leader Kim Ward, removes costs associated with genetic testing and counseling for Pennsylvania with a family history of breast and ovarian cancer. Senator Ward, who was diagnosed with breast cancer in 2020, discovered a genetic mutation in BRCA2 through genetic testing.
“Informed decisions about our health now, can save the lives of future generations. Senate Act 1330 is an important step on our path to ensuring early detection and targeted treatments are possible for women with a history of breast and ovarian cancer,” Senator Kim Ward said. Get genetically tested, I know how much this legislation will affect families across the state.”
Both bills will now be referred to the House of Representatives.
Senator Ward and Pennsylvania Senator Christina Tartaglione (D-Philadelphia) today announced the approval of a Senate resolution designating October 2022 as Breast Cancer Awareness Month and Friday, October 21, 2022, as Pennsylvania Mammography Day. The resolution serves as a reminder of the importance of the annual performances.
“Every family, including mine, has been affected by breast cancer in some way and knows the devastating effects this disease can have,” said Senator Tartaleni, one of the sponsors of the resolution. “When breast cancer is caught early, the 5-year survival rate for breast cancer is over 90 percent. We hope to encourage all women on Mammography Day and throughout Breast Cancer Awareness Month, to schedule annual mammograms, which are covered for free at Pennsylvania state “.
The PA Breast Cancer Coalition is a 501(c)3 organization that represents, supports, and serves breast cancer survivors and their families in Pennsylvania through educational programs, legislative advocacy, and breast cancer research grants. PBCC is a statewide non-profit organization dedicated to find a cure Currently…so that our girls don’t have to. For more information, please call 800-377-8828 or visit www.PABreastCancer.org.
For more information on Senator Minch’s legislation, visit www.senatormensch.com. State updates can also be found on Facebook’s Senator Mensch at facebook.com/PASenatorBobMensch/ or Twitter Tweet embed.
Contact: Lidia Di Fiore email@example.com (215) 541-2388